Related references
Note: Only part of the references are listed.Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease
Xiaodi Sun et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Synthesis and cellular evaluation of click-chemistry probes to study the biological effects of alpha, beta-unsaturated carbonyls
Chiara Morozzi et al.
REDOX BIOLOGY (2022)
Electrophile versus oxidant modification of cysteine residues: Kinetics as a key driver of protein modification
Max B. Sauerland et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2022)
The immunology of multiple sclerosis
Kathrine E. Attfield et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1
Sruthi Unni et al.
FEBS JOURNAL (2021)
Oxidative/Nitroxidative Stress and Multiple Sclerosis
Tobore Onojighofia Tobore
JOURNAL OF MOLECULAR NEUROSCIENCE (2021)
Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics
Anna Signorile et al.
ANTIOXIDANTS (2021)
Kinetic assessment of Michael addition reactions of alpha, beta-unsaturated carbonyl compounds to amino acid and protein thiols
Max Sauerland et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)
Amnon A. Berger et al.
NEUROLOGY INTERNATIONAL (2021)
Effect of biologics targeting interleukin-23/-17 axis on subclinical atherosclerosis: results of a pilot study
M. Marovt et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs
Jennifer A. Ward et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Effective Method for Accurate and Sensitive Quantitation of Rapid Changes of Newly Synthesized Proteins
Ming Tong et al.
ANALYTICAL CHEMISTRY (2020)
Galectin-1 Facilitates Macrophage Reprogramming and Resolution of Inflammation Through IFN-β
Hiba Yaseen et al.
FRONTIERS IN PHARMACOLOGY (2020)
Electrophilic Nrf2 activators and itaconate inhibit inflammation at low dose and promote IL-1β production and inflammatory apoptosis at high dose
Jonathan Muri et al.
REDOX BIOLOGY (2020)
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Stephanie Kourakis et al.
PHARMACEUTICALS (2020)
Diroximel fumarate to treat multiple sclerosis
Y. Wang et al.
DRUGS OF TODAY (2020)
Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4-MyD88 Complex
Balyn W. Zaro et al.
JOURNAL OF IMMUNOLOGY (2019)
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study
Michael J. Palte et al.
ADVANCES IN THERAPY (2019)
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks
Esther von Stebut et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Identification of Novel Protein Targets of Dimethyl Fumarate Modification in Neurons and Astrocytes Reveals Actions Independent of Nrf2 Stabilization
Gerardo G. Piroli et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Engineering Reactive Oxygen Species-Resistant Galectin-1 Dinners with Enhanced Lectin Activity
Margaret M. Fettis et al.
BIOCONJUGATE CHEMISTRY (2018)
Altered expression of matrix remodelling associated 7 (MXRA7) in psoriatic epidermis: Evidence for a protective role in the psoriasis imiquimod mouse model
Jinling Ning et al.
EXPERIMENTAL DERMATOLOGY (2018)
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Juergen Brueck et al.
EXPERIMENTAL DERMATOLOGY (2018)
Iron Drives T Helper Cell Pathogenicity by Promoting RNA-Binding Protein PCBP1-Mediated Proinflammatory Cytokine Production
Zhizhang Wang et al.
IMMUNITY (2018)
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Michael D. Kornberg et al.
SCIENCE (2018)
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Evanna L. Mills et al.
NATURE (2018)
Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
Irida Kastrati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Isabel Lastres-Becker et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Ulf Schulze-Topphoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells
Megan M. Blewett et al.
SCIENCE SIGNALING (2016)
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells
Megan M. Blewett et al.
SCIENCE SIGNALING (2016)
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease by modifying the Nrf2-Keap1 pathway
Kunitoshi Kobayashi et al.
INTERNATIONAL IMMUNOLOGY (2015)
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
Geoffrey O. Gillard et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
DIMETHYL FUMARATE ATTENUATES 6-OHDA-INDUCED NEUROTOXICITY IN SH-SY5Y CELLS AND IN ANIMAL MODEL OF PARKINSON'S DISEASE BY ENHANCING NRF2 ACTIVITY
X. Jing et al.
NEUROSCIENCE (2015)
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro
Melanie S. Brennan et al.
PLOS ONE (2015)
The Succinated Proteome of FH-Mutant Tumours
Ming Yang et al.
METABOLITES (2014)
Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype
Ran Rostoker et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Validation of the multiple sensor mechanism of the Keap1-Nrf2 system
Kai Takaya et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Global quantification of mammalian gene expression control
Bjoern Schwanhaeusser et al.
NATURE (2011)
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions
Jack van Horssen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Oxidative stress in the pathogenesis of psoriasis
Qiang Zhou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1
Nikolaos Paschalidis et al.
JOURNAL OF NEUROINFLAMMATION (2009)
The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer
T. Rantanen
BRITISH JOURNAL OF DERMATOLOGY (2008)
Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients
M. Hirotani et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death
Marta A. Toscano et al.
NATURE IMMUNOLOGY (2007)
Novel oral agents for multiple sclerosis
Jodie M. Burton et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2007)
Experimental encephalomyelitis induces changes in DJ-1: Implications for oxidative stress in multiple sclerosis
Nirit Lev et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2
Casey M. Clements et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses
Marta A. Toscano et al.
JOURNAL OF IMMUNOLOGY (2006)
Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress
HM Li et al.
FREE RADICAL RESEARCH (2005)
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
RM Canet-Avilés et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis
M Dias-Baruffi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression of annexin-1 in multiple sclerosis plaques
S Probst-Cousin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2002)
Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides
CW Tornoe et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice
L Santucci et al.
HEPATOLOGY (2000)
Share Paper
